furoscix

Quote
anonymous said:
LOL! It’s not always greener on the other side. A lot of companies are shady. The pay is decent by the way, but you’re right about the car allowance. My poor car has been taking a beating and what they are paying is not enough… For the car that is.

You are right about SB. I heard somebody in Florida sued her and 1 and her entire team testified against her but they all pretty much left and she’s still there. my manager is OK, but he thinks that she is crazy as well. She’s kind of creepy looking.

It’s not a bad job. I think it’s better than big Pharma. I think if they remove a few of the bad seeds, things would improve big time
Click to expand...
Please tell me the basis of the lawsuit against SB! I interviewed with her and I got the heebee jeebees from her. I decided not to pursue it.
 






Seems like a sinking ship... employees just milking checks until the well runs dry or they get another opportunity at a company with better long term prospects. Definitely hiring and only able to retain the bottom of the barrel talent.
 






Is it really as bad as people are suggesting?

The product appears to be growing in popularity based on the quarterly numbers. Anyone have good experiences, or is it all bad?
 












anonymous said:
Why is the stock getting absolutely pulverized? Down >40% ytd
Click to expand...
My guess is that the market is not expecting strong growth, and that the quarterly results most recently mixed expectations - largely in part due to a one time financing expense, I believe, as well as due to a somewhat small revenue miss, potentially attributable to the coverage gap rebates as discussed on the Q3 conference call.

Management seems to feel that Q4 was going better at the time of the call, and expects more tailwinds in Q1 2025 onwards with the potentially favorable updates to Schedule D, amongst other things. Just my 2 cents. Please verify all of this, and do not take it as authoritative in any way. Always do your own due diligence. This is not financial advice.
 






Could it be everyone has figured out you can do the same thing by just giving them a higher dose of bumex for cents on the dollar?

anonymous said:
My guess is that the market is not expecting strong growth, and that the quarterly results most recently mixed expectations - largely in part due to a one time financing expense, I believe, as well as due to a somewhat small revenue miss, potentially attributable to the coverage gap rebates as discussed on the Q3 conference call.

Management seems to feel that Q4 was going better at the time of the call, and expects more tailwinds in Q1 2025 onwards with the potentially favorable updates to Schedule D, amongst other things. Just my 2 cents. Please verify all of this, and do not take it as authoritative in any way. Always do your own due diligence. This is not financial advice.
Click to expand...
 






























anonymous said:
Ok Steve
Click to expand...
lol huh?

I am simply sharing the corporate update that is easily accessible on Yahoo Finance.

I don't know anyone at the company. It sounds like there are at least some people who have had bad experiences with management there.

I'm truly sorry to hear that. I wonder if those experiences were isolated to a few people or if it's a greater problem. That's not for me to say.

From what I can see, it looks like the company is moving in the right direction as of late, and my hope is that things continue to improve and grow.

All the best.
 






anonymous said:
lol huh?

I am simply sharing the corporate update that is easily accessible on Yahoo Finance.

I don't know anyone at the company. It sounds like there are at least some people who have had bad experiences with management there.

I'm truly sorry to hear that. I wonder if those experiences were isolated to a few people or if it's a greater problem. That's not for me to say.

From what I can see, it looks like the company is moving in the right direction as of late, and my hope is that things continue to improve and grow.

All the best.
Click to expand...
Ok “not Steve”
 






anonymous said:
Ok “not Steve”
Click to expand...
lol I honestly am not sure how to convince you that I am just someone who follows the company online... I don't think anything I say would convince you that I am "not Steve", and attempting to do so would be a fruitless endeavor anyway. It looks like there are people who have had a bad experience with management there. Not all that unique, I suppose. I think they're turning things around in terms of sales, but I have no idea what it's like working there. My hope is that there are many happy people working there who aren't as motivated to post about their experiences online, but who knows. In any event, I wish everyone good luck. Hoping to see Furoscix help as many people as possible.
 












Looks like capped copays might help with helping prospective patients gaining access to Furoscix, thanks to changes to Medicare Part D. I'm not sure if that's the case, but it seems like the company is optimistic about that change that came into effect at the beginning of this year. Not sure if President Trump will be changing that, but I suppose only time will tell.
 






























Top Bottom
Back
Quote